t. Journ 
          Psych. 168, 679-687.</li>
        <li class="texto">O&#8217;Brien, J. T. &amp; Levy, R.: (1992) Age associated 
          memory impairment (editorial) (see comments). BMJ. 304, 5-6</li>
        <li class="texto">Orrell, M. y Bebbington, P.: (1995) Social factors and 
          psychiatric admission for senile dementia. Int. J. Geriat. Psych. 10: 
          313-323</li>
        <li class="texto">Ott, A., Breteler, M. M., de Bruyne, M. C., van Harskamp, 
          F., Grobbee D. E. y Hofman, A.: Atrial fibrillation and dementia in 
          a population-based study. The Rotterdam Study. Stroke 1997; 28: 316-321.</li>
        <li class="texto">Ott, A., Slooter, A. J. C. y Hofman, A. et al.: Smoking 
          and risk of dementia and Alzheimer&#8217;s disease in a population-based 
          cohort study: the Rotterdam Study. Lancet 1998; 351: 1841-1843.</li>
        <li class="texto">Pinel, P. H.: (1798) Nosographie Philosophique ou la 
          methode. 6th (1818) ed. Vol. 1. Brosson, Paris.</li>
        <li class="texto">Pitas, R. E., Boyles, J. K. y Lee, S. H. et al.: (1987) 
          Lipoproteins and their receptors in the central nervous system. Characterization 
          of the lipoproteins in cerebrospinal fluid and identification of apolipoprotein 
          B,E (LDL) receptors in the brain. J. Biol. Chem. 1987, 262, 14352-14360.</li>
        <li class="texto">Plasman, B. et al.: (1996) APOE and cognitive decline 
          in Alzheimer&#8217;s disease. Neurology, 47: 317-320.</li>
        <li class="texto">Price-Evans, D. A., Mahgoub, A., Sloan, T. P., Idle, 
          J. R. y Smith, R. L.: A family and population study of the genetic polymorphism 
          of debrisoquine oxidation in a white British population. J. Med. Genet. 
          1980; 17: 102-105.</li>
        <li class="texto">Prichard, J. C.: (1835) Treatise on Insanity and other 
          disorders affecting the mind. Sherwood, London.</li>
        <li class="texto">Prince, M. J., Harwood, R., Thomas, A. y Mann, A. H.: 
          (1996) Gospel Oak V: Impairment, disability and handicap as risk factors 
          for depression in old age. Psychological Medicine 1996 (in press)</li>
        <li class="texto">Prince, M. J., Harwood, R., Thomas A. y Mann, A. H.: 
          (1996) Gospel Oak VI: Social support deficits, lonelyness, and life 
          events as risk factors for depression in old age. Psychological Medicine 
          1996 (in press)</li>
        <li class="texto">Prince, M., Harwood, R. y Thomas, A. et al.: A prospective 
          population-based cohort study of the effects of disablement and social 
          milieu on the onset and maintenance of late-life depression. The Gospel 
          Oak Project VII. Psychological Medicine, 1998, 28, 337-350.</li>
        <li class="texto">Prince, M. J., Lewis, G. y Bird, A. et al.: (1996) A 
          longitudinal Study of factors predicting change in cognitive test scores 
          over time, in an older hypertensive population. Psychological Medicine. 
          26, 555-568.</li>
        <li class="texto">Prince, M. J.: (1995) Vascular risk factors and atherosclerosis 
          as risk factors for cognitive decline and dementia. Journal of Psychosomatic 
          Research 39, 5, 525-530.</li>
        <li class="texto">Prince, M. J., Bird, A. S. y Blizard, R. A. et al.: 
          (1996b) Is the cognitive function of older patients affected by antihypertensive 
          treatment? Results from 54 months of the Medical Research Council&#8217;s 
          treatment trial of hypertension in older adults. British Medical Journal. 
          312: 801-805.</li>
        <li class="texto">Prince, M., Rabe-Hesketh, S. &amp; Brennan, P.: (1998) 
          Do antiarthritic drugs decrease the risk for cognitive decline? An analysis 
          based on data from the MRC treatment trial of hypertension in older 
          adults. Neurology. 50 (2): 374-379.</li>
        <li class="texto">Prince, M. J., Cullen, M. C., &amp; Mann, A. H. (1994). 
          Risk factors for Alzheimer&#8217;s disease and dementia: A case-control 
          study based on the MRC Elderly Hypertension Trial. Neurology 44: 97-104.</li>
        <li class="texto">Prince, M. J.: Vascular risk factors and artherosclerosis 
          as risk factors for cognitive decline and dementia. Journal of Psychosomatic 
          Research, 1995, vol 39, 5, 525-530.</li>
        <li class="texto">Prince, M. J., Harwood, R. H. y Blizard, R. A. et al.: 
          Impairment, disability and handicap as risk factors for depression in 
          old age. The Gospel Oak Project V. Psychological Medicine, 1997, 27 
          (2), 311-321.</li>
        <li class="texto">Raven, J. C.: (1940) Matrix Tests. Mental Health. 1: 
          10-18.</li>
        <li class="texto">Reltan, R. M.: (1959) Validity of the Trail Making Test 
          as an indication of organic brain damage. Perceptual Motor Skills. 8: 
          271-276.</li>
        <li class="texto">Riggs, J. E.: Smoking and Alzheimer&#8217;s disease: 
          protective effect or differential survival bias? The Lancet. 1993: 342: 
          793-794.</li>
        <li class="texto">Roman, G. C., Tatemichi, T. K. y Erkinjuntti, T. et 
          al.: Vascular dementia: Diagnostic criteria for research studies. Report 
          of the NINDS-AIREN International Workshop. Neurology 1993; 43: 250-260.</li>
        <li class="texto">Rorsman, B., Hagnell, O. y Lanke, J.: (1986) Prevalence 
          and incidence of senile and multi-infarct dementia in the Lundby study: 
          a comparison between the time periods 1947-1957 and 1957-1972. Neuropsychobiology 
          15, 122-129.</li>
        <li class="texto">Roses, A. D., Einstein, G. y Gilbert, J. et al.: Morphological, 
          biochemical, and genetic support for an apolipoprotein E effect on microtubular 
          metabolism. Ann. N. Y. Acad. Sci. 1996; 777: 146-157.</li>
        <li class="texto">Roth, M., Tym, E. y Mountjoy, C. Q. et al.: CAMDEX. 
          A standardised instrument for the diagnosis of mental disorder in the 
          elderly with special reference to the early detection of dementia. British 
          Journal of Psychiatry 1986; 149: 698-709.</li>
        <li class="texto">Saag, K. G., Rubenstein, L. M. y Chrischilles, E. A. 
          et al.: (1995) Nonsteroidal antiinflammatory drugs and cognitive decline 
          in the elderly. Journal of Rheumatology. 22 (11): 2142-2147.</li>
        <li class="texto">Saitoh, T., Xia, Y. y Chen. X. et al.: The CYP2D6B mutant 
          allele is overrepresented in the Lewy body variant of Alzheimer&#8217;s 
          disease. Annals of Neurology 1995; 37: 110-112.</li>
        <li class="texto">Sapolsky, R. M., Krey, L. C. y McEwen, B.: (1986) The 
          neuroendocrinology of stress and aging: the glucocorticoid cascade hypothesis. 
          Endocr. Rev. 7: 284-301.</li>
        <li class="texto">Saunders, A. M., Strittmatter, W. J. y Schmechel, D. 
          et al.: Association of apolipoprotein E allele e4 with late-onset familial 
          and sporadic Alzheimer&#8217;s disease. Neurology 1993; 43: 1467-1472.</li>
        <li class="texto">Schmand, B. y Smit.: (1997) The effects of intelligence 
          and education on the development of dementia: A test of the brain reserve 
          hypothesis. Psychological Medicine. 27 (6): 2490-2494.</li>
        <li class="texto">Shalat, A. L., Seltzer, B. y Pidcock, C. et al.: Risk 
          factors for Alzheimer&#8217;s disease. Neurology 1987; 37: 1295-1300.</li>
        <li class="texto">Shinton, R. y Beevers, G.: Metanalysis of the relation 
          between cigarette smoking and stroke. Br. Med. J. 1989, 298, 789-94</li>
        <li class="texto">Sing, C. F. y Davignon, J.: Role of the apolipoprotein 
          E polymorphism in determining normal plasma lipid and lipoprotein variation. 
          Am. J. Hum. Genet. 1985; 37: 268-285.</li>
        <li class="texto">Skoog, I., Lernfelt, B. y Landahl, S. et al.: 15-year 
          longitudinal study of blood pressure and dementia. The Lancet 1996; 
          347: 1141-1145.</li>
        <li class="texto">Small, B. J.: (1998) Three-year changes in cognitive 
          performance as a function of apolipoprotein E genotype: Evidence from 
          very old adults without dementia. Psychology &amp; Aging. 13 (1): 80-87</li>
        <li class="texto">Smits, C. et al.: Social participation and cognitive 
          function in older adults. Int. J. Geriat Psych. 10, 325-331</li>
        <li class="texto">Smith, G. E., Bohac, D. L. y Waring, et al.: (1998) 
          Apolipoprotein E genotype influences cognitive &#8216;phenotype&#8217; 
          in patients with Alzheimer&#8217;s disease but not in healthy control 
          subjects. Neurology. 50 (2): 355-362.</li>
        <li class="texto">Smith, C. A., Gough, A. C. y Leigh P. N. et al.: Debrisoquine 
          hydroxylase gene polymorphism and susceptibility to Parkinson&#8217;s 
          disease [published erratum appears in Lancet 1992 Jul. 4; 340 (8810): 
          64. Lancet 1992; 339: 1375-1377.</li>
        <li class="texto">Sobrino: (1791) Aumentado o nuevo diccionario de las 
          lenguas espanola, francesa y latina. 1st ed. JB Delamolliere, Le&oacute;n 
          de Francia.</li>
        <li class="texto">Sparks, D. L.: Coronary artery disease, hypertension, 
          ApoE, and cholesterol: a link to Alzheimer&#8217;s disease? Ann N. Y. 
          Acad. Sci. 1997; 826: 128-146.</li>
        <li class="texto">Speck, C. E., Kukull, W. A. y Brenner, D. E. et al.: 
          (1995) History of depression as a risk factor for Alzheimer&#8217;s 
          disease. Epidemiology. 6: 366-369.</li>
        <li class="texto">St Clair, D., Norrman, J., Perry, R., Yates, C., Wilcock, 
          G. y Brookes, A.: Apolipoprotein E 4 allele frequency in patients with 
          Lewy body dementia, Alzheimer&#8217;s disease and age-matched controls. 
          Neurosci Lett 1994; 176: 45-46.</li>
        <li class="texto">Stewart, R.: (1999) Hypertension and cognitive decline. 
          British Journal of Psychiatry. 174: 286-287.</li>
        <li class="texto">Streit, W. J. y Sparks, D. L.: Activation of microglia 
          in the brains of humans with heart disease and hypercholesterolemic 
          rabbits. J. Mol. Med. 1997; 75: 130-138.</li>
        <li class="texto">Strittmatter, W. J., Weisgraber, K. H. y Huang, D. Y. 
          et al.: Binding of human apolipoprotein E to synthetic amyloid beta 
          peptide: isoform-specific effects and implications for late-onset Alzheimer 
          disease. Proc. Natl. Acad. Sci. U.S.A 1993; 90: 8098-8102.</li>
        <li class="texto">Strittmatter, W. J., Saunders, A. M. y Goedert, M. et 
          al.: Isoform-specific interactions of apolipoprotein E with microtubule-associated 
          protein tau: implications for Alzheimer disease. Proc. Natl. Acad. Sci. 
          U.S.A. 1994; 91: 11183-11186.</li>
        <li class="texto">Strittmatter, W. J., Weisgraver, K. H. y Huang, D. Y. 
          et al.: (1993) Binding of human apolipoproten E to synthetic amyloid 
          beta peptide: isoform-specific effects and implications for late onset 
          Alzheimer&acute;s disease. Proc. Natl. Acad. Sci. U.S.A. 90, 8098-8102.</li>
        <li class="texto">Strong, C., Anderton, B. H., Perry, R. H., Perry, E. 
          K., Ince, P. G. y Lovestone, S.: Abnormally pshosphorilated Tau protein 
          in senile dementia of Lewy body type and Alzheimer disease: evidence 
          that the disorders are distinct. Alz. Dis. societ relat dis. 1995; 9: 
          218-222.</li>
        <li class="texto">Sullivan, G. F., Copeland, J. R. H., Dewey, M. E. &amp; 
          Davidson, A.: (1988) Benzodiazepiene usage among the elderly. International 
          Journal of Geriatric Psychiatry 3: 289-292.</li>
        <li class="texto">Swaab, D. F.: (1991) Brain ageing and Alzheimer&#8217;s 
          disease, &laquo;wear and tear&raquo; versus &laquo;use it or loose it&raquo;. 
          Neurobiology of Aging. 12: 317-324.</li>
        <li class="texto">Takahashi, S. et al.: (1992) Rabbit very low density 
          lipoprotein receptor: A low density lipoprotein receptor like protein 
          with distinc ligand specificity. Proc. Natl. Acad. Sci. U.S.A. 1992, 
          89, 9252-9256.</li>
        <li class="texto">Teresi, J. A., Golden, R. R. y Gurland, B. J. et al.: 
          Construct validity of indicator scales developed from the Comprehensive 
          Assessment and Referral Evaluation Interview Schedule. Journal of Gerontology, 
          1984, 39, 147-157.</li>
        <li class="texto">Teri, L., Hughes, J. P. y Larson, E. B.: Cognitive deterioration 
          in Alzheimer&#8217;s disease: behavioural and health factors. J. Gerontol 
          1990, 42, 3-10.</li>
        <li class="texto">The international classification of diseases 10th edition. 
          Chapter V: Mental and Behavioural disorders. World Health Organisation. 
          London. Churchill Livingstone, 1994.</li>
        <li class="texto">Tobiansky, R., Blizard, R., Livingston, G. y Mann, A.: 
          The Gospel Oak study stage IV: the clinical relevance of subjective 
          memory impairment in older people. Psychol Med. 25: 779-786</li>
        <li class="texto">Uusitupa, M., Sarkkinen, E., Kervinen, K. y Kesaniemi, 
          Y. A.: Apolipoprotein E phenotype and blood pressure. The Lancet 1994; 
          343: 57.</li>
        <li class="texto">Van Belle, G., Uhlmann, R. y Hughes, J. P. et al.: (1990) 
          Reliability of estimates of changes in mental status test performance 
          in senile dementia of the Alzheimer&#8217;s type. J. Clin. Epidemiol. 
          43: 589-595.</li>
        <li class="texto">Van Duijn, C. M. y Hofman, A.: Relation between nicotine 
          intake and Alzheimer&#8217;s disease. BMJ; 302: 1491-94</li>
        <li class="texto">Van Duijn, R., Stijner, T. y Hoffman, A.: Risk factors 
          for Alzheimers disease: An overview of the EURODEM collaborative re/analysis 
          of case/control studies. I. J. Epidemiology 1996; 20 (Suppl.): s4-s12.</li>
        <li class="texto">Van Duijn, C. M., Havekes, L. M., Van Broeckhoven, C., 
          de Knijff, P. y Hofman, A.: Apolipoprotein E genotype and association 
          between smoking and early onset Alzheimer&#8217;s disease. BMJ 1995; 
          310: 627-631.</li>
        <li class="texto">Walker: (1968) Crime and insanity in England, Historical 
          perspective. Vol. 1. Edimburgh University Press, Edimburgh.</li>
        <li class="texto">Webster, D. D.: Critical analysis of the disability 
          in Parkinsons disease. Mod. Treat 1968; 5: 257-287.</li>
        <li class="texto">Weich, S.: (1998) The Cohort Study. In Research Methods 
          in Psychiatric Epidemiology. Int. Rev. Psychiatry. 10, 4: 284-290.</li>
        <li class="texto">Weiler, P. G., Lubben, J. E. &amp; Chi, I.: (1991). 
          Cognitive impairment and hospital use. Am. J. Public Health. 81: 1153-1157.</li>
        <li class="texto">Wenham, P. R., Price, W. H. y Blandell, G.: Apolipoprotein 
          E genotyping by one-stage PCR. Lancet 1991; 337: 1158-1159.</li>
        <li class="texto">Weverling, Rijnsburger, A. W., Blauw, G. J., Lagaay, 
          A. M., Knook, D. L., Meinders, A. E. y Westendorp, R. G.: Total cholesterol 
          and risk of mortality in the oldest old. Lancet 1997; 350: 1119-1123.</li>
        <li class="texto">Whittington, J. E. y Huppert, F. A.: Smoking and cognitive 
          decline. Human psychopharmacology. 1997. vol 12 (5), 467-480.</li>
        <li class="texto">Wilson, P. W., Myers, R. H., Larson, M. G., Ordovas, 
          J. M., Wolf, P. A. y Schaefer, E. J.: Apolipoprotein E alleles, dyslipidemia, 
          and coronary heart disease. The Framingham Offspring Study. JAMA 1994; 
          272: 1666-1671.</li>
        <li class="texto">World Health organization: (1994) The international 
          clasification of diseases tenth edition, chapter five: Mental and behavioural 
          disorders. 10th ed. Churchill Livingstone, London.</li>
        <li class="texto">Ziehen, T.: (1911) Les demencies. In: Traite international 
          psychologie pathologique. Vol. 2. (Ed: Marie, A.) Alcan, Paris, 281-381.</li>
        <li><span class="texto" align="left">Zubenko, G. S., y Moosy, J.: (1988) 
          Major depression in primary dementia: Clinical and neuropathological 
          correlates. Arch. Neurol. 45: 1182-1186. </span></li>
      </ul>
      <p><span class="texto"><br>
        </span> </p>
      <ul>
        <div align="right"><a href="02_160_indice.htm" target="_self" class="textob">&lt;&lt; 
          volver</a> </div>
      </ul>
      <p align="right" class="texto">&nbsp;</td>
  </tr>
</table>
</body>
</html>